Kestra Medical Technologies, Ltd. logo

Kestra Medical Technologies, Ltd. (KMTS)

Market Open
1 Sep, 18:41
NASDAQ (NGS) NASDAQ (NGS)
$
25. 59
-0.16
-0.6237%
$
1.5B Market Cap
- P/E Ratio
- Div Yield
172,580 Volume
- Eps
$ 25.75
Previous Close
Analysts:
Add Transaction
Day Range
25.35 26.18
Year Range
15.42 30
Want to track KMTS and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

KMTS trading today lower at $25.59, a decrease of -0.6237% from yesterday's close, completing a monthly decrease of -0.7393% or -$0.19. Over the past 12 months, KMTS stock lost -3.1805%.
KMTS is not paying dividends to its shareholders.
The last earnings report, released on Apr 20, 2026, exceeded the consensus estimates by 0.5961%. On average, the company has surpassed earnings expectations by 0.3758%, based on the last three reports.
The stock of the company had never split.
The company's stock is traded on one exchange.

KMTS Chart

People also search for

Ichor Holdings Ltd.
$ 51.94
-3.0398%
Formula Systems (1985) Ltd. American Depositary Receipt
$ 126
+0.2227%
ChipMOS Technologies Inc.
$ 57.12
+4.5388%
SolarEdge Technologies Inc.
$ 32.24
+0.1242%
Progress Software Corporation
$ 44.82
-3.1338%
Strength Seen in Kestra Medical Technologies, Ltd. (KMTS): Can Its 8.1% Jump Turn into More Strength?

Strength Seen in Kestra Medical Technologies, Ltd. (KMTS): Can Its 8.1% Jump Turn into More Strength?

Kestra Medical Technologies, Ltd. (KMTS) saw its shares surge in the last session with trading volume being higher than average.

Zacks | 3 weeks ago
Kestra Medical Technologies, Ltd. (KMTS) Q4 2026 Earnings Call Transcript

Kestra Medical Technologies, Ltd. (KMTS) Q4 2026 Earnings Call Transcript

Kestra Medical Technologies, Ltd. (KMTS) Q4 2026 Earnings Call Transcript

Seekingalpha | 1 month ago
Kestra Medical Technologies, Ltd. (KMTS) Reports Q4 Loss, Tops Revenue Estimates

Kestra Medical Technologies, Ltd. (KMTS) Reports Q4 Loss, Tops Revenue Estimates

Kestra Medical Technologies, Ltd. (KMTS) came out with a quarterly loss of $0.67 per share versus the Zacks Consensus Estimate of a loss of $0.59.

Zacks | 1 month ago

Kestra Medical Technologies, Ltd. Investors

Name Quantity Cost Value Profit ($) Gain (%)
Curtis Ellergodt
Curtis Ellergodt Rothschild Investment LLC
25 $518.24 $631.75 $113.51 21.9%
SN
Stephanie Nee HARBOR CAPITAL ADVISORS Inc.
15,648 $312,825.09 $413,107.2 $100,282.11 32.06%
GN
Gina Nelson Next Century Growth Investors LLC
458,505 $11.67M $12.85M $1.18M 10.07%
Point72 Asset Management LP
Point72 Asset Management LP Point72 Asset Management LP
526,626 $10.75M $14.76M $4.01M 37.32%
Joseph Castro
Joseph Castro Nuveen LLC
96,015 $1.93M $2.72M $794,005.82 41.18%

Kestra Medical Technologies, Ltd. Analysts

Name Quantity Cost Value Profit ($) Gain (%)
Marie Thibault
Marie Thibault BTIG
781.76 $21,811.05 $21,811.05 - -

Kestra Medical Technologies, Ltd. (KMTS) FAQ

What is the stock price today?

The current price is $25.59.

On which exchange is it traded?

Kestra Medical Technologies, Ltd. is listed on NASDAQ (NGS).

What is its stock symbol?

The ticker symbol is KMTS.

Does it pay dividends? What is the current yield?

It does not pay dividends to its shareholders.

What is its market cap?

As of today, the market cap is 1.5B.

Has Kestra Medical Technologies, Ltd. ever had a stock split?

No, there has never been a stock split.

Kestra Medical Technologies, Ltd. Profile

Electronic Equipment, Instruments & Components Industry
Information Technology Sector
Brian Webster CEO
NASDAQ (NGS) Exchange
G52441105 CUSIP
US Country
443 Employees
- Last Dividend
- Last Split
- IPO Date

Overview

Kestra Medical Technologies, Ltd. is a pioneering company in the realm of wearable medical devices and digital healthcare solutions, rooted in the mission to enhance patient outcomes specifically regarding cardiovascular diseases. The organization was founded in 2014 and is located in Kirkland, Washington. Through the integration of innovative monitoring and therapeutic intervention technologies that are designed to be intuitive, intelligent, and connected, Kestra aims to revolutionize how cardiology is approached. The company centers its efforts on its flagship product, the Cardiac Recovery System platform, which unifies monitoring, therapeutic treatment, digital health, and patient support services into a comprehensive solution for managing cardiac health.

Products and Services

Kestra Medical Technologies offers an array of products and services designed to improve patient engagement and outcomes in the context of cardiovascular care. Below are the key components of their product offering:

  • Cardiac Recovery System Platform

    The core of Kestra's offerings is the Cardiac Recovery System platform, which integrates advanced monitoring and therapeutic solutions tailored for patients at risk of heart-related incidents. This platform is geared towards creating a seamless experience for both patients and healthcare providers.

  • ASSURE Wearable Cardioverter Defibrillator (WCD)

    This device is an essential feature of the Cardiac Recovery System, designed specifically for patients who are at an increased risk of sudden cardiac arrest (SCA). It provides life-saving capabilities by continuously monitoring the heart's rhythms and delivering shock therapy when necessary, thereby protecting patients in critical situations.

  • Integrated Digital Solutions

    Kestra also provides a suite of digital solutions that enhance patient and provider engagement. These tools facilitate real-time communication and support, allowing for proactive management of patient care and more informed decision-making by health professionals.

  • Patient Support Services

    The company's offerings go beyond technology; they include robust patient support services aimed at ensuring adherence to therapy and providing guidance throughout the recovery process. This holistic approach is designed to empower patients in managing their cardiovascular health effectively.

Contact Information

Address: 3933 Lake Washington Blvd NE
Phone: 425 279 8002